| 名称 | 获配股数 | 占全球发售 | 占上市后总股本 | 锁定期 |
|---|---|---|---|---|
| Boyu Capital Opportunities Master Fund | 0 | 4.00% | — | 6个月 |
| Hudson Bay Master Fund LTD | 0 | 5.00% | — | 6个月 |
| Invesco Advisers, Inc. | 0 | 14.10% | — | 6个月 |
| Lake Bleu Prime Healthcare Master Fund Limited | 0 | 4.00% | — | 6个月 |
| LAV Star Limited | 0 | 5.00% | — | 6个月 |
| Octagon Investments Master Fund LP | 0 | 4.00% | — | 6个月 |
| OrbiMed Genesis Master Fund,L.P. | 0 | 3.20% | — | 6个月 |
| Sage Partners Master Fund | 0 | 3.20% | — | 6个月 |
| Springhill Master Fund Limited | 0 | 5.00% | — | 6个月 |
| Tencent Mobility Limited | 0 | 4.00% | — | 6个月 |
| UBS Asset Management (Singapore) Ltd. | 0 | 10.00% | — | 6个月 |
本页展示 微泰医疗器械(杭州)股份有限公司 - B - H股(02235)的打新中签分析:一手中签率、甲乙组中签分布、超额认购倍数、暗盘与首日表现。数据来自港交所配发结果公告。中签率的计算方式与回拨规则见港股中签率怎么算。

